Pirkko Härkönen (P L Härkönen)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Breast Cancer Cells

Top Venues

Nature reviews. Cancer

Cellular oncology (Dordrecht)

This page only lists publications with an associated author ORCID identifier.

Publications

Matti Poutanen, Malin Hagberg Thulin, Pirkko Härkönen
Targeting sex steroid biosynthesis for breast and prostate cancer therapy. Nature reviews. Cancer (2023)
T E Kähkönen, M Toriseva, N Petruk, A-R Virta, A Maher, N Eigéliené, J Kaivola, P Boström, I Koskivuo, M Nees, J M Tuomela, K K Ivaska, Pirkko Härkönen
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures. Cellular oncology (Dordrecht) 44 (1) (2020)